BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 20204158)

  • 1. Bioimaging of nucleolin aptamer-containing 5-(N-benzylcarboxyamide)-2'-deoxyuridine more capable of specific binding to targets in cancer cells.
    Lee KY; Kang H; Ryu SH; Lee DS; Lee JH; Kim S
    J Biomed Biotechnol; 2010; 2010():168306. PubMed ID: 20204158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor targeting with a (99m)Tc-labeled AS1411 aptamer in prostate tumor cells.
    Noaparast Z; Hosseinimehr SJ; Piramoon M; Abedi SM
    J Drug Target; 2015; 23(6):497-505. PubMed ID: 25673264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell-SELEX-based selection of aptamers that recognize distinct targets on metastatic colorectal cancer cells.
    Li WM; Bing T; Wei JY; Chen ZZ; Shangguan DH; Fang J
    Biomaterials; 2014 Aug; 35(25):6998-7007. PubMed ID: 24857291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell Surface Nucleolin as a Promising Receptor for Effective AS1411 Aptamer-Mediated Targeted Drug Delivery into Cancer Cells.
    Mosafer J; Mokhtarzadeh A
    Curr Drug Deliv; 2018; 15(9):1323-1329. PubMed ID: 30039760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A nucleolin-targeted multimodal nanoparticle imaging probe for tracking cancer cells using an aptamer.
    Hwang DW; Ko HY; Lee JH; Kang H; Ryu SH; Song IC; Lee DS; Kim S
    J Nucl Med; 2010 Jan; 51(1):98-105. PubMed ID: 20008986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer cell targeting using multiple aptamers conjugated on nanorods.
    Huang YF; Chang HT; Tan W
    Anal Chem; 2008 Feb; 80(3):567-72. PubMed ID: 18166023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular imaging of a cancer-targeting theragnostics probe using a nucleolin aptamer- and microRNA-221 molecular beacon-conjugated nanoparticle.
    Kim JK; Choi KJ; Lee M; Jo MH; Kim S
    Biomaterials; 2012 Jan; 33(1):207-17. PubMed ID: 21944470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Novel AS1411 Aptamer-Based Three-Way Junction Pocket DNA Nanostructure Loaded with Doxorubicin for Targeting Cancer Cells in Vitro and in Vivo.
    Taghdisi SM; Danesh NM; Ramezani M; Yazdian-Robati R; Abnous K
    Mol Pharm; 2018 May; 15(5):1972-1978. PubMed ID: 29669200
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Smart AS1411-aptamer conjugated pegylated PAMAM dendrimer for the superior delivery of camptothecin to colon adenocarcinoma in vitro and in vivo.
    Alibolandi M; Taghdisi SM; Ramezani P; Hosseini Shamili F; Farzad SA; Abnous K; Ramezani M
    Int J Pharm; 2017 Mar; 519(1-2):352-364. PubMed ID: 28126548
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aptamer-nanoparticle bioconjugates enhance intracellular delivery of vinorelbine to breast cancer cells.
    Zhou W; Zhou Y; Wu J; Liu Z; Zhao H; Liu J; Ding J
    J Drug Target; 2014 Jan; 22(1):57-66. PubMed ID: 24156476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanoparticle-aptamer conjugates for cancer cell targeting and detection.
    Estévez MC; Huang YF; Kang H; O'Donoghue MB; Bamrungsap S; Yan J; Chen X; Tan W
    Methods Mol Biol; 2010; 624():235-48. PubMed ID: 20217600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeted delivery of doxorubicin to cancer cells by a cruciform DNA nanostructure composed of AS1411 and FOXM1 aptamers.
    Abnous K; Danesh NM; Ramezani M; Charbgoo F; Bahreyni A; Taghdisi SM
    Expert Opin Drug Deliv; 2018 Nov; 15(11):1045-1052. PubMed ID: 30269603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selection of RNA aptamers against recombinant transforming growth factor-beta type III receptor displayed on cell surface.
    Ohuchi SP; Ohtsu T; Nakamura Y
    Biochimie; 2006 Jul; 88(7):897-904. PubMed ID: 16540230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The nucleolin targeting aptamer AS1411 destabilizes Bcl-2 messenger RNA in human breast cancer cells.
    Soundararajan S; Chen W; Spicer EK; Courtenay-Luck N; Fernandes DJ
    Cancer Res; 2008 Apr; 68(7):2358-65. PubMed ID: 18381443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The development and testing of aptamers for cancer.
    Barbas AS; White RR
    Curr Opin Investig Drugs; 2009 Jun; 10(6):572-8. PubMed ID: 19513946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bioactivity of 2'-deoxyinosine-incorporated aptamer AS1411.
    Fan X; Sun L; Wu Y; Zhang L; Yang Z
    Sci Rep; 2016 May; 6():25799. PubMed ID: 27194215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Co-delivery of doxorubicin and aptamer against Forkhead box M1 using chitosan-gold nanoparticles coated with nucleolin aptamer for synergistic treatment of cancer cells.
    Khademi Z; Lavaee P; Ramezani M; Alibolandi M; Abnous K; Taghdisi SM
    Carbohydr Polym; 2020 Nov; 248():116735. PubMed ID: 32919550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aptamer-based tumor-targeted drug delivery for photodynamic therapy.
    Shieh YA; Yang SJ; Wei MF; Shieh MJ
    ACS Nano; 2010 Mar; 4(3):1433-42. PubMed ID: 20166743
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Real-time imaging of protein internalization using aptamer conjugates.
    Li W; Yang X; Wang K; Tan W; He Y; Guo Q; Tang H; Liu J
    Anal Chem; 2008 Jul; 80(13):5002-8. PubMed ID: 18533682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In situ labeling and imaging of cellular protein via a bi-functional anticancer aptamer and its fluorescent ligand.
    Ai J; Li T; Li B; Xu Y; Li D; Liu Z; Wang E
    Anal Chim Acta; 2012 Sep; 741():93-9. PubMed ID: 22840709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.